Literature DB >> 33822195

Prognostication for meningiomas: H3K27me3 to the rescue?

Sandro Santagata1,2,3,4, Keith L Ligon1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33822195      PMCID： PMC8328006          DOI： 10.1093/neuonc/noab083

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

1.  Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.

Authors:  Leah M Katz; Thomas Hielscher; Benjamin Liechty; Joshua Silverman; David Zagzag; Rajeev Sen; Peter Wu; John G Golfinos; David Reuss; Marian Christoph Neidert; Hans-Georg Wirsching; Peter Baumgarten; Christel Herold-Mende; Wolfgang Wick; Patrick N Harter; Michael Weller; Andreas von Deimling; Matija Snuderl; Chandra Sen; Felix Sahm
Journal:  Acta Neuropathol       Date:  2018-04-07       Impact factor: 17.088

2.  Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.

Authors:  Pooja Panwalkar; Jonathan Clark; Vijay Ramaswamy; Debra Hawes; Fusheng Yang; Christopher Dunham; Stephen Yip; Juliette Hukin; Yilun Sun; Matthew J Schipper; Lukas Chavez; Ashley Margol; Melike Pekmezci; Chan Chung; Adam Banda; Jill M Bayliss; Sarah J Curry; Mariarita Santi; Fausto J Rodriguez; Matija Snuderl; Matthias A Karajannis; Amanda M Saratsis; Craig M Horbinski; Anne-Sophie Carret; Beverly Wilson; Donna Johnston; Lucie Lafay-Cousin; Shayna Zelcer; David Eisenstat; Marianna Silva; Katrin Scheinemann; Nada Jabado; P Daniel McNeely; Marcel Kool; Stefan M Pfister; Michael D Taylor; Cynthia Hawkins; Andrey Korshunov; Alexander R Judkins; Sriram Venneti
Journal:  Acta Neuropathol       Date:  2017-07-21       Impact factor: 17.088

3.  Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.

Authors:  Guillaume Gauchotte; Matthieu Peyre; Celso Pouget; Dominique Cazals-Hatem; Marc Polivka; Fabien Rech; Pascale Varlet; Hugues Loiseau; Stéphanie Lacomme; Karima Mokhtari; Michel Kalamarides; Franck Bielle
Journal:  J Neuropathol Exp Neurol       Date:  2020-05-24       Impact factor: 3.685

4.  Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Authors:  Arjen H G Cleven; Ghadah A Al Sannaa; Inge Briaire-de Bruijn; Davis R Ingram; Matt van de Rijn; Brian P Rubin; Maurits W de Vries; Kelsey L Watson; Keila E Torres; Wei-Lien Wang; Sjoerd G van Duinen; Pancras C W Hogendoorn; Alexander J Lazar; Judith V M G Bovée
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

5.  H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.

Authors:  Felix Behling; Christina Fodi; Irina Gepfner-Tuma; Kristina Kaltenbach; Mirjam Renovanz; Frank Paulsen; Marco Skardelly; Jürgen Honegger; Marcos Tatagiba; Jens Schittenhelm; Ghazaleh Tabatabai
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

6.  A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.

Authors:  Sriram Venneti; Mariarita Santi; Michelle Madden Felicella; Dmitry Yarilin; Joanna J Phillips; Lisa M Sullivan; Daniel Martinez; Arie Perry; Peter W Lewis; Craig B Thompson; Alexander R Judkins
Journal:  Acta Neuropathol       Date:  2014-09-09       Impact factor: 17.088
  6 in total
  1 in total

1.  Loss of H3K27me3 in WHO grade 3 meningioma.

Authors:  Andrea Daniela Maier; Christian Beltoft Brøchner; Christian Mirian; Jeppe Haslund-Vinding; Jiri Bartek; Tomas J Ekström; Frantz Rom Poulsen; David Scheie; Tiit Mathiesen
Journal:  Brain Tumor Pathol       Date:  2022-06-09       Impact factor: 3.154
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.